Stryker Balance Sheet Health

Financial Health criteria checks 4/6

Stryker has a total shareholder equity of $18.6B and total debt of $13.0B, which brings its debt-to-equity ratio to 69.9%. Its total assets and total liabilities are $39.9B and $21.3B respectively. Stryker's EBIT is $4.2B making its interest coverage ratio 15. It has cash and short-term investments of $3.1B.

Key information

69.9%

Debt to equity ratio

US$13.00b

Debt

Interest coverage ratio15x
CashUS$3.05b
EquityUS$18.59b
Total liabilitiesUS$21.32b
Total assetsUS$39.91b

Recent financial health updates

Recent updates

Stryker: A Great Company At An Expensive Price

Apr 05

Stryker's (NYSE:SYK) Dividend Will Be $0.80

Mar 26
Stryker's (NYSE:SYK) Dividend Will Be $0.80

Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Mar 25
Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Stryker (NYSE:SYK) Hasn't Managed To Accelerate Its Returns

Mar 14
Stryker (NYSE:SYK) Hasn't Managed To Accelerate Its Returns

At US$348, Is Stryker Corporation (NYSE:SYK) Worth Looking At Closely?

Feb 21
At US$348, Is Stryker Corporation (NYSE:SYK) Worth Looking At Closely?

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Feb 10
Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Stryker: A Dividend Growth Powerhouse I'd Like To Own

Feb 02

Stryker Corporation (NYSE:SYK) Analysts Are Pretty Bullish On The Stock After Recent Results

Feb 02
Stryker Corporation (NYSE:SYK) Analysts Are Pretty Bullish On The Stock After Recent Results

Stryker (NYSE:SYK) Seems To Use Debt Quite Sensibly

Jan 24
Stryker (NYSE:SYK) Seems To Use Debt Quite Sensibly

Here's Why We Think Stryker (NYSE:SYK) Might Deserve Your Attention Today

Jan 02
Here's Why We Think Stryker (NYSE:SYK) Might Deserve Your Attention Today

Stryker: Mako Shoulder And Spine Launches Are On The Way

Dec 31

Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Dec 22
Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Dec 08
Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Why Stryker Is An Awesome Healthcare Compounder

Nov 30

Is Now An Opportune Moment To Examine Stryker Corporation (NYSE:SYK)?

Nov 10
Is Now An Opportune Moment To Examine Stryker Corporation (NYSE:SYK)?

Investors Could Be Concerned With Stryker's (NYSE:SYK) Returns On Capital

Oct 19
Investors Could Be Concerned With Stryker's (NYSE:SYK) Returns On Capital

Stryker: Don't Buy This Dividend Champion (Yet)

Oct 13

Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Oct 08
Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Is Stryker (NYSE:SYK) A Risky Investment?

Sep 26
Is Stryker (NYSE:SYK) A Risky Investment?

Stryker: Procedure Volume Recovery And Mako's Leading Robotic Technology

Aug 22

Some Investors May Be Worried About Stryker's (NYSE:SYK) Returns On Capital

Jul 18
Some Investors May Be Worried About Stryker's (NYSE:SYK) Returns On Capital

Stryker Corporation's (NYSE:SYK) Intrinsic Value Is Potentially 18% Below Its Share Price

Jul 06
Stryker Corporation's (NYSE:SYK) Intrinsic Value Is Potentially 18% Below Its Share Price

These 4 Measures Indicate That Stryker (NYSE:SYK) Is Using Debt Reasonably Well

Jun 17
These 4 Measures Indicate That Stryker (NYSE:SYK) Is Using Debt Reasonably Well

Stryker: Good Prospects

Jun 14

With EPS Growth And More, Stryker (NYSE:SYK) Makes An Interesting Case

May 24
With EPS Growth And More, Stryker (NYSE:SYK) Makes An Interesting Case

Should You Think About Buying Stryker Corporation (NYSE:SYK) Now?

May 01
Should You Think About Buying Stryker Corporation (NYSE:SYK) Now?

Some Investors May Be Worried About Stryker's (NYSE:SYK) Returns On Capital

Apr 18
Some Investors May Be Worried About Stryker's (NYSE:SYK) Returns On Capital

Calculating The Fair Value Of Stryker Corporation (NYSE:SYK)

Apr 06
Calculating The Fair Value Of Stryker Corporation (NYSE:SYK)

Is Stryker (NYSE:SYK) Using Too Much Debt?

Feb 27
Is Stryker (NYSE:SYK) Using Too Much Debt?

Stryker: Typically Excellent, Typically Expensive

Feb 16

Stryker Has A Slowing FCF Conversion And No Plans Of Share Buyback

Feb 07

If EPS Growth Is Important To You, Stryker (NYSE:SYK) Presents An Opportunity

Feb 02
If EPS Growth Is Important To You, Stryker (NYSE:SYK) Presents An Opportunity

Stryker Non-GAAP EPS of $3.00 beats by $0.16, revenue of $5.2B beats by $230M

Jan 31

Stryker initiated at sector weight by KeyBanc on limited upside potential

Jan 25

Stryker: Excellent Recent And Continuing Performance

Jan 09

Be Wary Of Stryker (NYSE:SYK) And Its Returns On Capital

Jan 08
Be Wary Of Stryker (NYSE:SYK) And Its Returns On Capital

At US$243, Is It Time To Put Stryker Corporation (NYSE:SYK) On Your Watch List?

Dec 26
At US$243, Is It Time To Put Stryker Corporation (NYSE:SYK) On Your Watch List?

Stryker's (NYSE:SYK) Upcoming Dividend Will Be Larger Than Last Year's

Dec 14
Stryker's (NYSE:SYK) Upcoming Dividend Will Be Larger Than Last Year's

Calculating The Fair Value Of Stryker Corporation (NYSE:SYK)

Dec 12
Calculating The Fair Value Of Stryker Corporation (NYSE:SYK)

Stryker lifts dividend by 7.9% to $0.75/share

Dec 07

Financial Position Analysis

Short Term Liabilities: SYK's short term assets ($12.5B) exceed its short term liabilities ($7.9B).

Long Term Liabilities: SYK's short term assets ($12.5B) do not cover its long term liabilities ($13.4B).


Debt to Equity History and Analysis

Debt Level: SYK's net debt to equity ratio (53.5%) is considered high.

Reducing Debt: SYK's debt to equity ratio has reduced from 84% to 69.9% over the past 5 years.

Debt Coverage: SYK's debt is well covered by operating cash flow (28.6%).

Interest Coverage: SYK's interest payments on its debt are well covered by EBIT (15x coverage).


Balance Sheet


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.